Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Podium Presentation of NeuraGen(R) Nerve Guide Multi-Center Clinical Trial at ASSH
PLAINSBORO, N.J., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the Podium Presentation of A Collagen Conduit vs. Microsurgical Neurorrhaphy. Two-Year Follow up of a Prospective Blinded Clinical and Electrophysiological Multicenter RCT , at
View HTML
Toggle Summary Integra LifeSciences Announces Plans to Market INTEGRA Dermal Regeneration Template® through its Direct Sales Force
Integra LifeSciences Announces Plans to Market INTEGRA Dermal Regeneration Template® through its Direct Sales Force Alliance with ETHICON, Inc. to Terminate at end of 2003 Plainsboro, NJ / October 6, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that it
View HTML
Toggle Summary Integra LifeSciences Announces Plans for a Two-For-One Stock Split and Increase in Authorized Shares
PLAINSBORO, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its Board of Directors has recommended an increase in the number of authorized shares and a two-for-one stock split.   "The recommendation from the board of directors
View HTML
Toggle Summary Integra LifeSciences Announces Planned Restructuring of its European Operations
Integra LifeSciences Announces Planned Restructuring of its European Operations PLAINSBORO, N.J., June 1, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the planned reorganization of its European operations.
View HTML
Toggle Summary Integra LifeSciences Announces Participation in Upcoming Investor Conferences
PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: On September 7, 2022,  Jan De Witte , chief executive officer
View HTML
Toggle Summary Integra LifeSciences Announces Participation in Upcoming Investor Conferences
PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: On February 24, 2021, Carrie Anderson, executive vice president
View HTML
Toggle Summary Integra LifeSciences Announces Participation in Upcoming Investor Conferences
PRINCETON, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: On September 9, 2021, Carrie Anderson, executive vice president
View HTML
Toggle Summary Integra LifeSciences Announces New Three-Year Agreement With Premier
Premier Purchasing Partners Will Continue to Contract Jarit(R) Surgical and Laparoscopic Instruments
View HTML
Toggle Summary Integra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc.
Integra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc. PLAINSBORO, N.J., Oct. 1, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has entered into a development agreement pursuant to
View HTML
Toggle Summary Integra LifeSciences Announces NeuraGen(R) Clinical Study Published in Journal of Hand Surgery
Compares Entubulation Versus Standard Microsurgical Technique for the Primary Repair of Median and Ulnar Nerve Injuries in the Forearm
View HTML
Toggle Summary Integra LifeSciences Announces Multi-Year Agreement With Premier Purchasing Partners to Provide Neurosurgical Products
PLAINSBORO, N.J., Sept. 1, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has signed a new multi-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, to provide dural repair,
View HTML
Toggle Summary Integra LifeSciences Announces May 2020 Investor Conference Schedule
PRINCETON, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it will participate in two investor conferences in May. On May 12, 2020, Glenn Coleman, chief operating officer will present
View HTML
Toggle Summary Integra LifeSciences Announces Leadership Transition Plan
Jan De Witte to retire as CEO by the end of 2024 Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART), a leading global medical technology company, today
View HTML
Toggle Summary Integra LifeSciences Announces Launch of the Uni-CP Compression Plate
Integra Now Offers a Comprehensive Line of Anatomic Plates for Foot and Ankle Surgery
View HTML
Toggle Summary Integra LifeSciences Announces Launch of the Mobius™ Multi Modality Monitoring System
Integra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System PLAINSBORO, N.J., Oct 9, 2006 (PrimeZone Media Network via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the Mobius™ Multi Modality Monitoring
View HTML